medmix AG Capital Reinvestment Ratio
medmix AG capital reinvestment ratio. medmix AG (MEDX) has a Capital Reinvestment Ratio of 0.50x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF37.40 Million) in capital expenditures (CHF18.80 Million). See MEDX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of medmix AG (2018–2025)
Capital reinvestment ratio of medmix AG from 2018 to 2025. This chart tracks medmix AG's Capital Reinvestment Ratio across 8 annual periods. See medmix AG free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
medmix AG Capital Reinvestment Ratio by Year (2018–2025)
medmix AG capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see how efficiently does medmix AG generate cash.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | CHF67.80 Million | CHF34.50 Million | ▼ -9.1% |
| 2024 | 0.56x | CHF86.60 Million | CHF48.50 Million | ▼ -40.6% |
| 2023 | 0.94x | CHF56.10 Million | CHF52.90 Million | ▲ +16.3% |
| 2022 | 0.81x | CHF47.60 Million | CHF38.60 Million | ▲ +121.9% |
| 2021 | 0.37x | CHF87.30 Million | CHF31.90 Million | ▼ -57.1% |
| 2020 | 0.85x | CHF50.60 Million | CHF43.10 Million | ▲ +109.7% |
| 2019 | 0.41x | CHF89.10 Million | CHF36.20 Million | ▲ +27.6% |
| 2018 | 0.32x | CHF94.20 Million | CHF30.00 Million | — |